CompletedPhase 3NCT00365963
Official study title

Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers

Study summary

The purpose of this study is to find out if patients with lung cancer and their main informal caregiver (person providing physical, emotional, or financial support) are helped by getting information, support, and decision making tools through a computer system called CHESS(the Comprehensive Health Enhancement Support System)

Ask AI to explain this study
Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedComprehensive Health Enhancement Support System

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 6, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 3

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Wisconsin, Madison

Study sponsor

01
Study overview

What this study is about

Purpose
Other
Study type
Interventional
Phase
Phase 3
Sponsor
University of Wisconsin, Madison
Interventions being studied
Device: Comprehensive Health Enhancement Support System
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Advanced Non-Small Cell Lung Cancer (Stage III or Stage IV)
  • Needs to have a "caregiver" - a spouse, partner, family member, or friend providing emotional, physical, and/or financial support - to participate with the patient.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Wisconsin- Madison 610 Walnut St, WARF 1109AMadison, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 6, 2021. Always confirm current availability with the study team.

View original record ↗